Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2012-12-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UHT treated milk
1,5 L of 1,5% UHT milk pr day for 3 weeks (21days)
UHT treated milk
Paseurised milk
1,5 L 1,5% pasteurised milk pr day for 3 weeks (21 days)
UHT treated milk
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UHT treated milk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 22-50 years of age
* BMI 25-30
* non smokers
Exclusion Criteria
* milk allergy or other types of food allergy
* Intestinal, abdominal or endocrinnologic diseases
* daily use of dietary supplements incl. vitamins and minerals
* cronic diseases (diabetes, CVD etc.)
* user of medicin on perscription that can influence the resuts of the study
* allergic to paraamino benzoe acid
* Physical activity \> 10 h pr week
* Blood donor
* on a diet or change of dietary habits within 3 months
* body weigh change \> 3 kg within the last 3 month
* special diets
* concomitant participation on other studies
* not able to comply with protocol
22 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arla Foods
INDUSTRY
Hoeng Fonden
UNKNOWN
Bionor Pharma
UNKNOWN
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AAstrup
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition, Exercise and Sports
Copenhagen, Frederiksberg, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Janne Lorenzen, Ass.Prof.
Role: primary
Karina Sorensen, Msc
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B300
Identifier Type: -
Identifier Source: org_study_id